Micronutrients & recovery
Current anti-obesity medication (AOM) studies frequently misrepresent skeletal muscle mass (SMM) loss by using DXA or BIA to estimate fat-free mass (FFM) or lean mass, which includes bone and non-skeletal tissues, thereby confounding the assessment of clinically significant muscle loss.
When reading studies on weight loss drugs (like GLP-1 agonists) that report 'muscle loss' based on DXA or bioimpedance scales, recognize that these numbers likely overestimate true skeletal muscle loss because they include bone and water. True muscle loss is likely lower than reported in these specific studies. Look for studies using MRI or CT for accurate skeletal muscle quantification.
Most randomized, placebo- controlled studies addressing this question report on fat- free or lean mass estimated from dual- energy x- ray absorptiometry or bioelectrical impedance without defining the composition of these components. Fat- free, lean, and skeletal muscle mass are not synonymous terms, and studies frequently fail to define lean mass, which may or may not include bone.
Why this rating
Based on a comprehensive narrative review of multiple RCTs and established biophysical principles of body composition.
Source
Understanding Impact of Anti‐Obesity Medications on Skeletal Muscle Mass Change Is Confounded by Measurement Methods
Arden McMath et al. · Obesity Reviews · 2025
DOI 10.1111/obr.70041
More from this paper
- Skeletal muscle loss during pharmacologically induced weight loss is clinically significant because excessive SMM loss reduces resting energy expenditure (REE), making weight maintenance more difficult.Good
- Dietary protein intake and resistance exercise can attenuate fat-free mass and skeletal muscle loss during caloric restriction, but may not completely abrogate it.Good
Related findings · Micronutrients & recovery
- Trans fats (industrial trans-fatty acids) are unequivocally harmful and should be completely avoided as they raise LDL-C, TGs, and Apo B while lowering HDL-C.Strong
- For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.Strong
- Folic acid fortification of flour prevents neural tube birth defects, and mandatory fortification is more effective than voluntary supplementation alone.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →